000			01415 a2200325 4500
005			20250516103300.0
264		0	_c20130809
008			201308s 0 0 eng d
022			_a1875-6182
024	7		_a10.2174/1871525711311010012 _2doi
040			_aNLM _beng _cNLM
100	1		_aMorishita, Yoshiyuki
245	0	0	_aThe effects of direct renin inhibitor, aliskiren, on arterial hypertension, chronic kidney disease and cardiovascular disease: optimal pharmacotherapy. _h[electronic resource]
260			_bCardiovascular & hematological agents in medicinal chemistry _cMar 2013
300			_a77-82 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAmides _xtherapeutic use
650	0	4	_aAngiotensin Receptor Antagonists _xtherapeutic use
650	0	4	_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use
650	0	4	_aAntihypertensive Agents _xtherapeutic use
650	0	4	_aCardiovascular Diseases _xdrug therapy
650	0	4	_aFumarates _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aHypertension _xdrug therapy
650	0	4	_aRenal Insufficiency, Chronic _xdrug therapy
650	0	4	_aRenin _xantagonists & inhibitors
700	1		_aKusano, Eiji
773	0		_tCardiovascular & hematological agents in medicinal chemistry _gvol. 11 _gno. 1 _gp. 77-82
856	4	0	_uhttps://doi.org/10.2174/1871525711311010012 _zAvailable from publisher's website
999			_c21970709 _d21970709